BridgeMD
New treatment option for Thermal Ablation
Official title Ultrasound and Cytological Evaluation 3 Years After Radiofrequency Thermal Ablation of Benign Thyroid Nodules : a Prospective Exploratory Cohort of 180 Nodules
ClinicalTrials.gov ID: NCT05726981
What this study is testing
- What it's testing
- There is no scientific data on post-thermal ablation cytological aspects, but treated nodules that grow back significantly after a procedure justify a new cytology in order not to ignore a neoplastic process. The EU-TIRADS classification usually used to stratify the risk of cancer (and to justify a fine needle aspiration biopsy) of thyroid nodules is not validated for nodules treated by thermal ablation (TA) (post-RF nodules).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients \> 18 years old
- Carrier of a benign thyroid nodule that has undergone radiofrequency thermoablation 36 months previously ± 12 months +/- 1 month, whether the nodule...
- Obtaining written informed consent
- Affiliation to a social security system (excluding AME)
You likely can't join if
- Pregnant or breastfeeding women
- Previous alcohol use
- Patients on anti-vitamin K anticoagulants
- Patients on direct oral anticoagulants
- Persons deprived of liberty by judicial or administrative decision
- Persons under forced psychiatric care
See the full eligibility criteria
- Patients \> 18 years old
- Carrier of a benign thyroid nodule that has undergone radiofrequency thermoablation 36 months previously ± 12 months +/- 1 month, whether the nodule is stable, progressing or decreasing in volume during the screening...
- Obtaining written informed consent
- Affiliation to a social security system (excluding AME)
- Pregnant or breastfeeding women
- Previous alcohol use
- Patients on anti-vitamin K anticoagulants
- Patients on direct oral anticoagulants
- Persons deprived of liberty by judicial or administrative decision
- Persons under forced psychiatric care
- Persons admitted to a health or social institution for purposes other than research
- Persons of full age who are under legal protection (guardianship or curatorship)
- Persons unable to express their consent
- Persons under a legal protection measure (there can be no derogation for this category)
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.